International Examining the Drug Approval Process in Lebanon, Egypt, Algeria, and Gulf Arab Countries May 30, 2015 Nagi S. El Saghir, MDTwitter: @NagiSaghir Firas Kredidieh, MD References: Karam R, Raidy C, Charbel D, et al. Lebanese Ministry of Public Health. Manual for Administrative Procedures for Drugs & Pharmaceutical Products Registration, Version 2. moph.gov.lb/Publications/Documents/DrugsRegistration2014.pdf. Updated January 2014. Accessed January 26, 2015. Ministry of Public Health, Lebanon: Plant Profile. moph.gov.lb/Services/Documents/RI3DIEDv1-2012.pdf. Accessed February 9, 2015. Guidelines on Good Storage and Distribution Practices of Pharmaceutical Products in Lebanon. moph.gov.lb/Drugs/Documents/Guidelines-GSDPLebanon%28English%29.pdf. Accessed February 9, 2015. Drug Registration Requirements in Algeria. pharmabiz.com/Services/ExportImport/Countries/Algeria.aspx. Accessed January 26, 2015. Saudi Food and Drug Administration. Framework for Drug Approvals, Version 4. . Published June 2009. Accessed January 26, 2015. Kasteng F, Wilking N, Bengt Jönsson. Patient Access to Cancer Drugs in Nine Countries in the Middle East. comparatorreports.se/Middle%20East%20oncology%20drug%20uptake%20Final%20report%20Sept%2015%202008.pdf. Accessed January 26, 2015. El Saghir NS, Adebamowo CA, Anderson BO, et al. Breast cancer management in low resource countries (LRCs): Consensus statement from the Breast Health Global Initiative. Breast. 2011;20Suppl 2:S3-11.